AMERSHAM BIOSCIENCES
DEAD

Serial Number

78081610

Owner

AMERSHAM PLC

Attorney

Catherine Mennenga

Filing Date

Aug 29, 2001

Add to watchlist:

No watchlists yet
View on USPTO

AMERSHAM BIOSCIENCES Trademark

Serial Number: 78081610 • Registration: 2829777

AMERSHAM BIOSCIENCES is a trademark filed by AMERSHAM PLC on August 29, 2001. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

AMERSHAM PLC (44 trademarks)

BUCKINGHAMSHIRE HP7 9NA , GB

Entity Type: 03

GE HEALTHCARE LIMITED (94 trademarks)

AMERSHAM PLACE LITTLE CHALFONT
BUCKINGHAMSHIRE HP7 9NA , GB

Entity Type: 99

Trademark Details

Filing Date

August 29, 2001

Registration Date

April 6, 2004

Published for Opposition

November 19, 2002

Cancellation Date

November 12, 2010

Goods & Services

Educational services, namely, conducting classes and seminars in the field of medical imaging and diagnostics; holding seminars, conferences, symposiums and workshops relating to the pharmaceutical industry, for medical practitioners and employees of pharmaceutical companies

Scientific apparatus and instruments used for radiology for the purpose of measuring, monitoring and surveying; computers, printers, and software programs used for the purpose of life science research; radiology apparatus and instruments for the reading and interpretation of autoradiographs and films including automated film readers and scanners; apparatus for electrophoresis; chromatography columns and pumps; apparatus for microfabrication; apparatus for scintillation; imaging apparatus for radioactive and luminescent emissions; synthesis and purification integrated systems for use in radiology; apparatus manufacturing oligonucleotides; apparatus for microarrays; microarray slides; laboratory glassware; vials and microvials; microtitre plates; and parts and fittings for the aforesaid goods

Contrast media for medical imaging; diagnostic scanning agents for in vivo use; radiopharmaceutical products for clinical, medical, scientific, and research use; radioactive sources and standards for use in nuclear medicine; radioactive pharmaceutical preparations and non-radioactive reagents for producing radiopharmaceuticals for in vivo diagnostic or therapeutic use; pharmaceutical preparations for use in diagnosis; pre-filled vials containing medical diagnostic reagents; pre-filled cartridges containing saline solution

Chemicals and chemical reagents for use in industry, science and research; biochemical and biological preparations for use in industry, science and research; chemical preparations for scientific purposes; preparations for diagnosis for scientific purposes; radioactive elements, isotopes, preparations and reagents for industrial, research and scientific purposes

Surgical and medical apparatus and instruments used for the purpose of measuring, monitoring and surveying in the field of radio therapy, comprised of medical needles, suture needles, implantable radiation therapy devices consisting of encapsulated radioisotope brachytherapy sources, radiation therapy delivery system consisting primarily of radioactive seeds and a bioabsorbable carrier assembly; magnetic resonance imagers, MRI; x-ray apparatus for medical use; x-ray diagnostic apparatus, computerized tomography, CAT, scanners and ultrasound imagers; radiological apparatus for diagnostic and medical purposes; test kits for clinical medical use comprised of test tubes, test plates and indicator charts for evaluating test results; vials; cannulas; vials access cannulas; syringes; injectors; cartridges; infusion pumps for intravenous administration of fluids; needles for medical purposes and parts and fittings for the aforesaid goods

Advisory services for pharmaceutical companies in the field of purification and chromatography research and development services in the field of pharmaceutical and life sciences; high through put screening assays for drug development services; customer synthesis services consisting of isotopically labeling chemical biological molecules; and analytical services in the chemical analytical field, the diagnostic field, and the medical imaging field

Filing History

CANCELLED SEC. 8 (6-YR)
Nov 12, 2010 C8..
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 18, 2005 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 18, 2005 REAP
REGISTERED-PRINCIPAL REGISTER
Apr 6, 2004 R.PR
SEC. 44(E) CLAIM ADDED
Jan 8, 2004 44EA
Sec. 1(B) CLAIM DELETED
Jan 8, 2004 1.BD
CASE FILE IN TICRS
Sep 2, 2003 CFIT
PETITION TO DIRECTOR GRANTED
Aug 14, 2003 PCGR
NOTICE OF ALLOWANCE CANCELLED
Aug 11, 2003 IUCN
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 7, 2003 CRFA
SOU TEAS EXTENSION RECEIVED
Aug 7, 2003 EEXT
PAPER RECEIVED
Aug 5, 2003 MAIL
PETITION TO DIRECTOR RECEIVED
May 5, 2003 PCRC
PAPER RECEIVED
May 5, 2003 MAIL
NOA MAILED - SOU REQUIRED FROM APPLICANT
Feb 11, 2003 NOAM
PUBLISHED FOR OPPOSITION
Nov 19, 2002 PUBO
NOTICE OF PUBLICATION
Oct 30, 2002 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 16, 2002 CNSA
EXAMINERS AMENDMENT MAILED
Sep 16, 2002 CNEA
ASSIGNED TO EXAMINER
Aug 13, 2002 DOCK
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Aug 13, 2002 ZZZX
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 5, 2002 CNSA
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 26, 2002 CRFA
PAPER RECEIVED
Apr 26, 2002 MAIL
NON-FINAL ACTION MAILED
Nov 2, 2001 CNRT
ASSIGNED TO EXAMINER
Oct 25, 2001 DOCK